Photo taken from Hanneke Pouw/LinkedIn
Jun 11, 2024, 13:03
Hanneke Pouw: Tomorrow I’ll present our work in an oral presentation at the SNMMI24 in Toronto!
Hanneke Pouw, Amsterdam UMC, shared on LinkedIn:
“Tomorrow I’ll present our work in an oral presentation at the SNMMI24 in Toronto!
In this work supported by Boehringer Ingelheim we demonstrated Target Engagement and Saturating Effects in the Therapeutic Anti-SIRPα Antibody BI 765063 with quantitative immunoPET.
I’m really happy to have the opportunity to share our results and to connect with people in the field together with colleagues from the Amsterdam UMC and cancer center Amsterdam.
Session details: 10.35 – SS27 Oncology Basic: Preclinical and Early Clinical Development of Novel Radiopharmaceuticals.”
Source: Hanneke Pouw/LinkedIn
